Cite
Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
MLA
van de Laar, Thijs J., et al. “Blood Donor Screening in the Netherlands: Universal Anti-HBc Screening in Combination with HBV Nucleic Acid Amplification Testing May Allow Discontinuation of Hepatitis B Virus Antigen Testing.” Transfusion, vol. 61, no. 7, July 2021, pp. 2116–24. EBSCOhost, https://doi.org/10.1111/trf.16420.
APA
van de Laar, T. J., Hogema, B. M., Molenaar-de Backer, M. W., Marijt-van der Kreek, T., & Zaaijer, H. L. (2021). Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. Transfusion, 61(7), 2116–2124. https://doi.org/10.1111/trf.16420
Chicago
van de Laar, Thijs J, Boris M Hogema, Marijke W Molenaar-de Backer, Tanneke Marijt-van der Kreek, and Hans L Zaaijer. 2021. “Blood Donor Screening in the Netherlands: Universal Anti-HBc Screening in Combination with HBV Nucleic Acid Amplification Testing May Allow Discontinuation of Hepatitis B Virus Antigen Testing.” Transfusion 61 (7): 2116–24. doi:10.1111/trf.16420.